2023
DOI: 10.1158/1078-0432.22462133.v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Supplemental Methods from GTL001, A Therapeutic Vaccine for Women Infected with Human Papillomavirus 16 or 18 and Normal Cervical Cytology: Results of a Phase I Clinical Trial

Abstract: <p>Supplemental Methods</p>

Help me understand this report
View published versions

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles